セフチゾキシムナトリウム
セフチゾキシムナトリウム 価格
もっと(1)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
Sigma-Aldrich Japan
|
A3612 |
セフチゾキシム ナトリウム塩
Ceftizoxime sodium salt |
68401-82-1 |
50mg |
¥93200 |
2023-06-01 |
購入 |
セフチゾキシムナトリウム 化学特性,用途語,生産方法
効能
抗生物質, 細胞壁合成阻害薬
商品名
エポセリン (長生堂製薬)
説明
Ceftizoxime was synthesized by Fujisawa Pharmaceutical Industries in 1979. It possesses the (iminothiazolyl)methoxyiminomethyl group at the 7 position of the cephem nucleus, but there is no side chain at the 3 position. The compound shows excellent activity against gram-positive and gram-negative bacteria, behavior similar to that of cefotaxime. Unlike cefotaxime, however, it is not metabolized in vivo.
化学的特性
Cefotaxime Sodium is white, white or light yellow crystalline powder; odorless; insoluble in organic solvents but soluble in water. The 10% solution has a pH of 4.5 to 6.5. Dilute solution is colorless or yellowish while high-concentration solution is grayish yellow. Dark yellow or brown color indicates that the drug has been deteriorated. The aqueous solution can be stored at 5 ℃ for 1 week.
使用
Antibacterial.
定義
ChEBI: The sodium salt of ceftizoxime.
臨床応用
Ceftizoxime (Cefizox) is a third-generation cephalosporinthat was introduced in 1984. This β-lactamase–resistant agentexhibits excellent activity against the Enterobacteriaceae,especially E. coli, K. pneumoniae, E. cloacae, Enterobacteraerogenes, indole-positive and indole-negative Proteus spp.,and S. marcescens. Ceftizoxime is claimed to be more activethan cefoxitin against B. fragilis. It is also very active againstGram-positive bacteria. Its activity against P. aeruginosa issomewhat variable and lower than that of either cefotaxime orcefoperazone.
Ceftizoxime is not metabolized in vivo. It is excretedlargely unchanged in the urine. Adequate levels of the drugare achieved in the cerebrospinal fluid for the treatment ofGram-negative or Gram-positive bacterial meningitis. It mustbe administered on a thrice-daily dosing schedule because ofits relatively short half-life. Ceftizoxime sodium is very stablein the dry state. Solutions maintain potency for up to 24hours at room temperature and 10 days when refrigerated.
セフチゾキシムナトリウム 上流と下流の製品情報
原材料
準備製品
セフチゾキシムナトリウム 生産企業
Global( 260)Suppliers
セフチゾキシムナトリウム スペクトルデータ(1HNMR、13CNMR、IR1、IR2)
68401-82-1(セフチゾキシムナトリウム)キーワード:
- 68401-82-1
- Ceftix
- Ceftizoxime, sodium salt
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, [6R-[6α,7β(Z)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-
- Ceftizon
- Eposerin
- Sodium 7-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-cephem-4-carboxylate
- monosodium salt, (6r-(6-alpha,7-beta(z)))- (methoxyimino)acetyl)amino)-8-oxo-,
- Monosodium(6R,7R)-7-[[(2-aminothiazol-4yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-Carboxylate
- (6r,7r)-7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt
- CEFTIZOXIMESODIUM(MONOSODIUM(6R,7R)-7-[[(2-AMINOTHIAZOL-4YL)-2-METHOXYIMINOACETYLAMINO]-8-OXO-5-THIA-1-AZABICYCLO[4,2,0]OCT-2-ENE-2-CARBOXYLATE)
- SKF-88373-Z
- Ceftizoxime sodiumUSP,
850-995 ug (HPLC)
- ceftizoxim-natrium
- fk749
- fr-13,479
- skf-88373
- CEFTIZOXIME SODIUM
- )-(methoxyimino)acetyl)amino)-8-oxo-,monosodiumsalt,(6r-(6-alpha,7-beta(z))
- sodium 7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Ceftizoxime sodium USP/EP/BP
- Ceftizoxime sodiumQ: What is
Ceftizoxime sodium Q: What is the CAS Number of
Ceftizoxime sodium Q: What is the storage condition of
Ceftizoxime sodium
- TIANFUCHEM--68401-82-1--Ceftizoxime sodium
- Cefizox
- Monosodium Salt, Ceftizoxime
- Cefazoxime sodium
- 2-Propen-1-one,1-[(2S,5S)-2-(hydroxymethyl)-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
- (6R,7R)-7-[[(Z)-(2-アミノ-4-チアゾリル)(メトキシイミノ)アセチル]アミノ]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸ナトリウム
- (6R,7R)-7α-[2-(2-イミノ-4-チアゾリン-4-イル)-2-[(Z)-メトキシイミノ]アセチルアミノ]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸ナトリウム
- (6R,7R)-7-[(Z)-2-(2-アミノチアゾール-4-イル)-2-(メトキシイミノ)アセチルアミノ]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸ナトリウム
- セフチゾキシムナトリウム
- セフチゾキシム ナトリウム塩
- セフチゾキシムナトリウム (JP17)
- ナトリウム (6R,7R)-7-[(2Z)-2-(2-イミノ-2,3-ジヒドロ-1,3-チアゾール-4-イル)-2-(メトキシイミノ)アセトアミド]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボキシラート
- セフチゾン
- セファロスポリン類